Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin, diclofenac or naproxen for prevention of post‑ERCP pancreatitis
IRCT2014100111192N3Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute pancreatitis (AP) comparing Indomethacin arm, Diclofenac arm and Naproxen arm (3 arms). Primary endpoint: Incidence of post-ERCP pancreatitis. Started Jan 2015; status: completed.
02
Drugs
indomethacindiclofenacnaproxen
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on IRCT2014100111192N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014100111192N3.